Covered recipient · General Payments record
JAMES T BONUCCHI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$194,706.61
- Reported across 847 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,262.50 | 5 |
| Food and Beverage | $1,532.60 | 86 |
| Consulting Fee | $675.00 | 1 |
| Travel and Lodging | $34.28 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $5,328.53 | 24 |
| Amgen Inc. | $155.06 | 11 |
| DEXCOM, INC. | $150.23 | 16 |
| Novo Nordisk AS | $144.41 | 9 |
| RECORDATI_RARE_DISEASES_INC. | $125.31 | 3 |
| Lilly USA, LLC | $122.21 | 7 |
| PFIZER INC. | $86.11 | 5 |
| CHIESI USA, INC. | $58.80 | 3 |
| Corcept Therapeutics | $52.61 | 2 |
| Antares Pharma, Inc. | $51.24 | 3 |
| Radius Health, Inc. | $47.94 | 2 |
| Averitas Pharma Inc. | $42.63 | 2 |
| Neurocrine BioSciences, Inc. | $25.10 | 1 |
| Alvogen Inc | $22.73 | 1 |
| Insulet Corporation | $16.79 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.96 | 1 |
| Acerta Pharma LLC | $15.75 | 1 |
| SANOFI-AVENTIS U.S. LLC | $15.23 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.56 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (95)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.